期刊
CLINICAL PHARMACOLOGY & THERAPEUTICS
卷 91, 期 3, 页码 380-383出版社
NATURE PUBLISHING GROUP
DOI: 10.1038/clpt.2011.318
关键词
-
Since 2004, the Critical Path Initiative has prompted industry, academia, and government agencies to work together to share the information, technology, and expertise critical to modernize and transform our approach to drug development and review. Various collaborations have been sharing data in a precompetitive space, establishing data standards, and facilitating collective tool development. As a result, the organization is making progress toward developing knowledge and tools that can reduce uncertainty in medical product development.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据